Kyntra Bio (KYNB) Other Accumulated Expenses (2014 - 2018)

Kyntra Bio has reported Other Accumulated Expenses for 5 years, with the latest figure at $5.5 million in Q4 2018.

• Quarterly Other Accumulated Expenses fell 14.26% year-over-year to $5.5 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $5.5 million (down 14.26% YoY) and the FY2018 annual result came in at $5.5 million, down 14.26% from the prior year.
• Other Accumulated Expenses slipped to $5.5 million in Q4 2018 per KYNB's latest filing, from $9.6 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $10.3 million in Q3 2017 and troughed at $3.2 million in Q2 2015.
• A 5-year average of $6.2 million and a median of $5.6 million in 2014 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2015 and 2017: Other Accumulated Expenses declined 14.32% in 2015, then soared 83.46% in 2017.
• Over 5 years, Other Accumulated Expenses stood at $5.6 million in 2014, then slipped by 14.32% to $4.8 million in 2015, then gained by 14.01% to $5.4 million in 2016, then rose by 18.95% to $6.5 million in 2017, then dropped by 14.26% to $5.5 million in 2018.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $5.5 million, $9.6 million, and $8.8 million for Q4 2018, Q3 2018, and Q2 2018 respectively.